Sanofi

Update in progress

SNY (NasdaqGS)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - General

Sanofi is a global biopharmaceutical company that researches, develops, manufactures and markets medicines and vaccines across immunology, inflammation, oncology, rare diseases and neurology. It offers pediatric vaccines (polio, pertussis, Hib), RSV protection and hexavalent vaccines. The company pursues collaborations with Exscientia, Atomwise, Insilico Medicine, Kymera, Nurix, Denali, Adagene, Scribe, Teva and Provention Bio, among others. Headquartered in Paris.

Company score

Sentiment: 0.99; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.39; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.87; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.69; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.25; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.62; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive